Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning and Dissemination Grant - Institute Community Support

McGill University

$10,000.00

8th Canadian Symposium on Hepatitis C virus

EF 2018-19

Résumé
Hepatitis C virus (HCV) affects at least 268,000 Canadians and causes more years of life lost than any infectious disease in the country. The CIHR and the Public Health Agency of Canada (PHAC) have identified liver disease due to HCV as a major public health problem. Providing better care for HCV-infected individuals requires integration between researchers and policy makers across the four CIHR pillars (Biomedical, Clinical, Health services and Social, Cultural, Environmental, and Population Health). Over the past 8 years, the National Canadian Research Training Program in Hepatitis C (NCRTP-HepC), now called the Canadian Network on Hepatitis C Virus (CanHepC) have organized the Canadian Symposium on Hepatitis C Virus (CSHCV), leveraging funds from CIHR as well as industry sponsors. This symposium has been highly successful, and has promoted the exchange of ideas and expertise between social scientists, public health experts, economists, basic scientists, community members and clinicians all working towards the elimination of HCV in Canada. The goal of this CIHR Meetings, Planning and Dissemination Grant is to seek support for the 8th symposium, to be held on May 24th, 2018 in Montreal. The theme of this year's symposium will be "Improving Diagnosis: identifying the undiagnosed population" and will focus on strategies to identify the undiagnosed population of HCV-infected individuals in Canada and link them to care. In recent years, new therapies have been approved by Health Canada leading to higher rates of HCV eradication and shortened courses of therapy. Thus, identification of the HCV-infected population is important for disease eradication in Canada. Several limitations also remain with respect to treatment uptake, including financial, geographical, cultural and social barriers. We aim to address these challenges at the CSHCV and encourage collaboration and exchange among researchers, policy makers and community members to achieve elimination of HCV in Canada.
Programme
Planning and Dissemination Grant - Institute Community Support
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
391949
Name
Sagan Selena M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Planning and Dissemination - III
Projecttitle
8th Canadian Symposium on Hepatitis C virus
Programtype2
Miscellaneous Programs
Orgnameinp2
McGill University
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Aboriginal Health; Clinical Sciences; Disease Burden In Canada; Epidemiology; Health Policy; Hepatitis C Virus; Marginalized Populations; Public Health; Social Sciences; Viral Hepatitis
Abstract
Hepatitis C virus (HCV) affects at least 268,000 Canadians and causes more years of life lost than any infectious disease in the country. The CIHR and the Public Health Agency of Canada (PHAC) have identified liver disease due to HCV as a major public health problem. Providing better care for HCV-infected individuals requires integration between researchers and policy makers across the four CIHR pillars (Biomedical, Clinical, Health services and Social, Cultural, Environmental, and Population Health). Over the past 8 years, the National Canadian Research Training Program in Hepatitis C (NCRTP-HepC), now called the Canadian Network on Hepatitis C Virus (CanHepC) have organized the Canadian Symposium on Hepatitis C Virus (CSHCV), leveraging funds from CIHR as well as industry sponsors. This symposium has been highly successful, and has promoted the exchange of ideas and expertise between social scientists, public health experts, economists, basic scientists, community members and clinicians all working towards the elimination of HCV in Canada. The goal of this CIHR Meetings, Planning and Dissemination Grant is to seek support for the 8th symposium, to be held on May 24th, 2018 in Montreal. The theme of this year's symposium will be "Improving Diagnosis: identifying the undiagnosed population" and will focus on strategies to identify the undiagnosed population of HCV-infected individuals in Canada and link them to care. In recent years, new therapies have been approved by Health Canada leading to higher rates of HCV eradication and shortened courses of therapy. Thus, identification of the HCV-infected population is important for disease eradication in Canada. Several limitations also remain with respect to treatment uptake, including financial, geographical, cultural and social barriers. We aim to address these challenges at the CSHCV and encourage collaboration and exchange among researchers, policy makers and community members to achieve elimination of HCV in Canada.
Competitiondate
201809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sagan, Selena M; Sebastiani, Giada
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Infection & Immunity~ $10,000~ $0~